These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1014 related articles for article (PubMed ID: 30173338)

  • 1. Variable response of subretinal hyperreflective material to anti-vascular endothelial growth factor classified with optical coherence tomography angiography.
    Maruyama-Inoue M; Sato S; Yamane S; Kadonosono K
    Graefes Arch Clin Exp Ophthalmol; 2018 Nov; 256(11):2089-2096. PubMed ID: 30173338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Vascular Versus Avascular Subretinal Hyperreflective Material With Aflibercept Response in Age-related Macular Degeneration.
    Kawashima Y; Hata M; Oishi A; Ooto S; Yamashiro K; Tamura H; Miyata M; Uji A; Ueda-Arakawa N; Tsujikawa A
    Am J Ophthalmol; 2017 Sep; 181():61-70. PubMed ID: 28669776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subretinal Hyperreflective Material Imaged With Optical Coherence Tomography Angiography.
    Dansingani KK; Tan ACS; Gilani F; Phasukkijwatana N; Novais E; Querques L; Waheed NK; Duker JS; Querques G; Yannuzzi LA; Sarraf D; Freund KB
    Am J Ophthalmol; 2016 Sep; 169():235-248. PubMed ID: 27349411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subretinal hyperreflective exudation associated with neovascular age-related macular degeneration.
    Shah VP; Shah SA; Mrejen S; Freund KB
    Retina; 2014 Jul; 34(7):1281-8. PubMed ID: 24695062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORRELATION OF SUBRETINAL HYPERREFLECTIVE MATERIAL MORPHOLOGY AND VISUAL ACUITY IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Kumar JB; Stinnett S; Han JIL; Jaffe GJ
    Retina; 2020 May; 40(5):845-856. PubMed ID: 31305505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compartmental Exudative Dynamics in Neovascular Age-Related Macular Degeneration: Volumetric Outcomes and Impact of Volatility in a Phase III Clinical Trial.
    Ehlers JP; Lunasco LM; Yordi S; Cetin H; Le TK; Sarici K; Kaiser PK; Khanani AM; Talcott KE; Hu J; Meng X; Srivastava SK
    Ophthalmol Retina; 2024 Aug; 8(8):765-777. PubMed ID: 38403242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. REGRESSION OF TYPE 2 NEOVASCULARIZATION INTO A TYPE 1 PATTERN AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
    Dolz-Marco R; Phasukkijwatana N; Sarraf D; Freund KB
    Retina; 2017 Feb; 37(2):222-233. PubMed ID: 27627752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy.
    Phasukkijwatana N; Tan ACS; Chen X; Freund KB; Sarraf D
    Br J Ophthalmol; 2017 May; 101(5):597-602. PubMed ID: 27503396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography Angiography of Type 1 Neovascularization in Age-Related Macular Degeneration.
    Kuehlewein L; Bansal M; Lenis TL; Iafe NA; Sadda SR; Bonini Filho MA; De Carlo TE; Waheed NK; Duker JS; Sarraf D
    Am J Ophthalmol; 2015 Oct; 160(4):739-48.e2. PubMed ID: 26164826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Responses of Types 1 and 2 Neovascularization in Age-Related Macular Degeneration to Anti-Vascular Endothelial Growth Factor Treatment: Optical Coherence Tomography Angiography Analysis.
    Kim JM; Cho HJ; Kim Y; Jung SH; Lee DW; Kim JW
    Semin Ophthalmol; 2019; 34(3):168-176. PubMed ID: 31132283
    [No Abstract]   [Full Text] [Related]  

  • 11. The association of exudation pattern with anatomical and functional outcomes in patients with Neovascular Age-Related Macular Degeneration.
    Inan S; Polat O; Karadas M; Inan UU
    Rom J Ophthalmol; 2019; 63(3):238-244. PubMed ID: 31687625
    [No Abstract]   [Full Text] [Related]  

  • 12. Macular Morphology and Visual Acuity in Year Five of the Comparison of Age-related Macular Degeneration Treatments Trials.
    Jaffe GJ; Ying GS; Toth CA; Daniel E; Grunwald JE; Martin DF; Maguire MG;
    Ophthalmology; 2019 Feb; 126(2):252-260. PubMed ID: 30189282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal Assessment of Ellipsoid Zone Integrity, Subretinal Hyperreflective Material, and Subretinal Pigment Epithelium Disease in Neovascular Age-Related Macular Degeneration.
    Ehlers JP; Zahid R; Kaiser PK; Heier JS; Brown DM; Meng X; Reese J; Le TK; Lunasco L; Hu M; Srivastava SK
    Ophthalmol Retina; 2021 Dec; 5(12):1204-1213. PubMed ID: 33640493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Fundus Autofluorescence after Anti-vascular Endothelial Growth Factor According to the Type of Choroidal Neovascularization in Age-related Macular Degeneration.
    Lee JY; Chung H; Kim HC
    Korean J Ophthalmol; 2016 Feb; 30(1):17-24. PubMed ID: 26865799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Time to Retreatment and Visual Function Between Ranibizumab and Aflibercept in Age-Related Macular Degeneration.
    Inoue M; Yamane S; Sato S; Sakamaki K; Arakawa A; Kadonosono K
    Am J Ophthalmol; 2016 Sep; 169():95-103. PubMed ID: 27320059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subretinal hyperreflective material morphology in neovascular age-related macular degeneration: A case control study.
    Alex D; Giridhar A; Gopalakrishnan M; Indurkhya S; Madan S
    Indian J Ophthalmol; 2021 Jul; 69(7):1862-1866. PubMed ID: 34146045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
    Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
    Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macular Morphology and Visual Acuity in the Second Year of the Comparison of Age-Related Macular Degeneration Treatments Trials.
    Sharma S; Toth CA; Daniel E; Grunwald JE; Maguire MG; Ying GS; Huang J; Martin DF; Jaffe GJ;
    Ophthalmology; 2016 Apr; 123(4):865-75. PubMed ID: 26783095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between neovascular lesion type and clinical characteristics of nonneovascular fellow eyes in patients with unilateral, neovascular age-related macular degeneration.
    Marsiglia M; Boddu S; Chen CY; Jung JJ; Mrejen S; Gallego-Pinazo R; Freund KB
    Retina; 2015 May; 35(5):966-74. PubMed ID: 25627089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.